video corpo

NGS reagent kit MiSeqDx Cystic Fibrosis DX-102-1001
diagnosticclinicalfor molecular biology

NGS reagent kit
NGS reagent kit
Add to favorites
Compare this product


diagnostic, NGS, clinical, for molecular biology
Tested parameter
for genes


Product Highlights Complete View of the CFTR Gene Capture all variants in the protein coding regions and intron/exon boundaries of the CFTR gene Accurate Results Deep coverage (> 3,000×) allows detection accuracy with a Positive Agreement (PA) of 99.66%* No Demographic Bias Sequencing the CFTR gene removes the bias inherent in existing genotyping panels1 * PA includes polyTG/polyT variants The MiSeqDx Cystic Fibrosis Clinical Sequencing Assay is the first FDA-cleared in vitro diagnostic (IVD) next-generation sequencing (NGS) test designed to sequence all protein coding regions and intron/exon boundaries of the CFTR gene, including two large deletions, two deep intronic mutations, and indels in homopolymeric regions such as the 2184delA deletion. The assay also automatically detects polyTG/polyT variants. Viewing the CFTR sequence eliminates any bias inherent in existing cystic fibrosis (CF) panels. As a result, the MiSeqDx Cystic Fibrosis Clinical Sequencing Assay can uncover rare mutations not accounted for in standard tests. Widely adopted next-generation sequencing The MiSeqDx Cystic Fibrosis Clinical Sequencing Assay provides a fully integrated molecular CF testing solution on the MiSeqDx instrument. Amplify 27 CFTR gene target regions in a single PCR step, and multiplex samples to streamline your workflow. Simply prepare libraries from 250 ng gDNA, load on to the MiSeqDx for sequencing using the Illumina sequencing by synthesis (SBS) chemistry, and analyze with the user-friendly software.


No catalogs are available for this product.

See all of Illumina, Inc.‘s catalogs
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.